GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX)

Symbol: FHTX on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$4,294,265	795,040	-13,448	-1.7%	$5.40	Q4 2025
30 Sep 2025	0%	0%	$3,954,505	808,488	+814	+0.1%	$4.89	Q3 2025
30 Jun 2025	0%	+0%	$3,796,954	807,674	+116,979	+17%	$4.70	Q2 2025
31 Mar 2025	0%	+0%	$2,521,872	690,695	+7,832		$3.65	Q1 2025
31 Dec 2024	0%	+0%	$3,224,191	682,863	+5,477	+0.81%	$4.72	Q4 2024
30 Sep 2024	0%	+0%	$6,308,176	677,386	+146,276	+28%	$9.31	Q3 2024
30 Jun 2024	0%	+0%	$3,054,191	531,110	+82,699	+18%	$5.75	Q2 2024
31 Mar 2024	0%	0%	$3,009,185	448,411	+61	+0.01%	$6.71	Q1 2024
31 Dec 2023	0%	+0%	$2,892,163	448,350	+22,268	+5.2%	$6.45	Q4 2023
30 Sep 2023	0%	+0%	$2,130,671	426,082	+19,534	+4.8%	$5.00	Q3 2023
30 Jun 2023	0%	+0%	$2,862,097	406,548	+20,540	+5.3%	$7.04	Q2 2023
31 Mar 2023	0%	+0%	$2,393,249	386,008	+15,759	+4.3%	$6.20	Q1 2023
31 Dec 2022	0%	+0%	$2,362,000	370,249	+1,622	+0.44%	$6.38	Q4 2022
30 Sep 2022	0%	+0%	$3,162,000	368,627	+12,120	+3.4%	$8.58	Q3 2022
30 Jun 2022	0%	+0%	$4,848,000	356,507	+6,323	+1.8%	$13.60	Q2 2022
31 Mar 2022	0%	+0%	$5,333,000	350,184	+2,789	+0.8%	$15.23	Q1 2022
31 Dec 2021	0%	+0%	$7,944,000	347,395	+74,688	+27%	$22.87	Q4 2021
30 Sep 2021	0%	+0%	$3,798,000	272,707	+34,963	+15%	$13.93	Q3 2021
30 Jun 2021	0%	+0%	$2,536,000	237,744	+91,104	+62%	$10.67	Q2 2021
31 Mar 2021	0%	+0%	$1,932,000	146,640	+14,128	+11%	$13.18	Q1 2021
31 Dec 2020	0%	+0%	$2,686,000	132,512	+132,512	NEW	$20.27	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.